hydantoins has been researched along with Myocardial Ischemia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breyer, RM; Ji, Y; Kong, D; Lazarus, M; Liu, G; Lu, A; Nakamura, M; Shen, Y; Stratakis, CA; Yu, Y; Zuo, S | 1 |
| Dong, DL; Du, ZM; Li, Z; Song, WH; Wang, HZ; Yang, BF | 1 |
| Ducouret, P; Ducroq, J; Gérard, JL; Puddu, PE; Rouet, R; Sallé, L; Tabourel, C | 1 |
| Bui-Xan, B; Chevalier, P; Dubieff, AD; Morel, E; Pineau, J; Piqueras, E; Rivard, L; Timour, Q | 1 |
| Kane, KA; McIntosh, MA; Pacini, D; Tanira, M | 1 |
| Connolly, SJ; Marcello, SR; Page, RL; Pritchett, EL; Schnell, DJ; Wilkinson, WE | 1 |
6 other study(ies) available for hydantoins and Myocardial Ischemia
| Article | Year |
|---|---|
PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.
Topics: Animals; Cecum; Cell Polarity; Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit; Disease Models, Animal; Female; Gene Deletion; Hydantoins; Inflammation; Janus Kinase 2; Ligation; Macrophages; Mice, Inbred C57BL; Myocardial Infarction; Myocardial Ischemia; Peritonitis; Prostaglandin D2; Protein Binding; Protein Subunits; Punctures; Receptors, Immunologic; Receptors, Interferon; Receptors, Prostaglandin; Signal Transduction; STAT1 Transcription Factor; Wound Healing; Zymosan | 2016 |
Acidification alters antiarrhythmic drug blockade of the ether-a-go-go-related Gene (HERG) Channels.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Delayed Rectifier Potassium Channels; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Hydantoins; Hydrogen-Ion Concentration; Imidazoles; Imidazolidines; Myocardial Ischemia; Oocytes; Patch-Clamp Techniques; Phenethylamines; Piperazines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quinidine; Sulfonamides; Transfection; Xenopus | 2004 |
Electrophysiological effects of azimilide in an in vitro model of simulated-ischemia and reperfusion in guinea-pig ventricular myocardium.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chromans; Dose-Response Relationship, Drug; Female; Guinea Pigs; Heart Ventricles; Hydantoins; Imidazolidines; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Phenethylamines; Piperazines; Potassium Channel Blockers; Sulfonamides; Time Factors | 2005 |
The impact of acute myocardial ischemia on the ventricular defibrillation threshold during chronic oral azimilide therapy.
Topics: Acute Disease; Administration, Oral; Animals; Anti-Arrhythmia Agents; Defibrillators, Implantable; Electric Countershock; Electrocardiography; Female; Hydantoins; Imidazolidines; Long QT Syndrome; Male; Myocardial Ischemia; Piperazines; Swine; Ventricular Fibrillation | 2007 |
Comparison of the cardiac electrophysiologic effects of NE-10064 with sotalol and E-4031 and their modification by simulated ischaemia.
Topics: Animals; Anti-Arrhythmia Agents; Hydantoins; Imidazoles; Imidazolidines; In Vitro Techniques; Myocardial Ischemia; Piperazines; Piperidines; Purkinje Fibers; Pyridines; Sheep; Sotalol | 1994 |
Dose-response relations of azimilide in the management of symptomatic, recurrent, atrial fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Comorbidity; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Hydantoins; Imidazoles; Imidazolidines; Male; Middle Aged; Myocardial Ischemia; Piperazines; Randomized Controlled Trials as Topic; Recurrence | 2001 |